Related Experiment Video
Updated: Jun 3, 2026
16:26
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
TLR2 signaling improves immunoregulation to prevent type 1 diabetes
Christophe M Filippi1, Katrin Ehrhardt, Elizabeth A Estes
1La Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA. cfilippi@gnf.org
European Journal of Immunology
|April 7, 2011
Summary
Toll-like receptor 2 (TLR2) signaling protects against type 1 diabetes (T1D) by enhancing regulatory T cells (Tregs). This pathway is crucial for both therapeutic interventions and viral protection from autoimmune diabetes.
Area of Science:
- Immunology
- Endocrinology
- Virology
Background:
- Toll-like receptor 2 (TLR2) signaling influences inflammation and regulatory T cell (Treg) populations.
- The role of TLR2 in the immunoregulation of type 1 diabetes (T1D) and its interaction with viral protection mechanisms requires elucidation.
Purpose of the Study:
- To investigate the mechanistic role of TLR2 in modulating immunoregulation within the context of type 1 diabetes (T1D).
- To determine if TLR2 mediates the protective effects of viral infections against autoimmune diabetes by influencing Tregs.
Main Methods:
- Treatment of prediabetic mice with a synthetic TLR2 agonist.
- Assessment of CD4(+) CD25(+) Treg cell number, function, and dendritic cell (DC) properties.
- Evaluation of T1D protection in wild-type (WT) and TLR2-deficient mice infected with lymphocytic choriomeningitis virus (LCMV).
Main Results:
- TLR2 agonist treatment diminished T1D incidence, increased Treg cell numbers and function, and induced tolerogenic DCs.
- TLR2 ligation enhanced Treg expansion and their capacity to prevent T1D.
- Protection from T1D by LCMV infection was dependent on TLR2, with increased Treg frequency and TGF-β production observed in WT mice.
Conclusions:
- TLR2 signaling promotes immunoregulation and controls autoimmune diabetes in both naive and infected states.
- TLR2 activation enhances Treg function and confers tolerogenic properties to DCs, offering a potential therapeutic target for T1D.
More Related Videos
Related Concept Videos
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...